🇰🇷 Evenity in South Korea

Evenity (romosozumab) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Evenity in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Bone approved in South Korea

Frequently asked questions

Is Evenity approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Evenity in South Korea?

Amgen is the originator. The local marketing authorisation holder may differ — check the official source linked above.